The?central nervous system?(CNS) is the part of the?nervous system?consisting of the?brain?and?spinal cord.
This report aims to provide a comprehensive presentation of the global market for Central Nervous System (CNS) Stimulant Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Central Nervous System (CNS) Stimulant Drugs. This report contains market size and forecasts of Central Nervous System (CNS) Stimulant Drugs in global, including the following market information:
Global Central Nervous System (CNS) Stimulant Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Central Nervous System (CNS) Stimulant Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The increasing prevalence of CNS disorders such as sleep apnea, narcolepsy, and attention-deficit hyperactivity across the world is increasing the sales and consumption of central nervous system stimulant drugs. Attention-deficit hyperactivity disorder, which is characterized by inattention, hyperactivity, and impulsivity interferes with the development and functioning of a person. Attention-deficit hyperactivity disorder is common among children and adolescents. Similarly, narcolepsy, a neurological sleep disorder, is characterized by chronic and excessive attacks of drowsiness during the day. The indication is common among children in their early childhood and older adults who are 50 years and above.
We surveyed the Central Nervous System (CNS) Stimulant Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Central Nervous System (CNS) Stimulant Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Central Nervous System (CNS) Stimulant Drugs Market Segment Percentages, by Type, 2022 (%)
Attention-deficit Hyperactivity Disorder
Narcolepsy
Others
Global Central Nervous System (CNS) Stimulant Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Central Nervous System (CNS) Stimulant Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Research Institutes and Research Institutions
Clinic
Other
Global Central Nervous System (CNS) Stimulant Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Central Nervous System (CNS) Stimulant Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Central Nervous System (CNS) Stimulant Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Central Nervous System (CNS) Stimulant Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline Plc
Johnson & Johnson Services Inc.
Novartis AG
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Central Nervous System (CNS) Stimulant Drugs, market overview.
Chapter 2: Global Central Nervous System (CNS) Stimulant Drugs market size in revenue.
Chapter 3: Detailed analysis of Central Nervous System (CNS) Stimulant Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Central Nervous System (CNS) Stimulant Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Central Nervous System (CNS) Stimulant Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Central Nervous System (CNS) Stimulant Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Central Nervous System (CNS) Stimulant Drugs Overall Market Size
2.1 Global Central Nervous System (CNS) Stimulant Drugs Market Size: 2022 VS 2030
2.2 Global Central Nervous System (CNS) Stimulant Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Central Nervous System (CNS) Stimulant Drugs Players in Global Market
3.2 Top Global Central Nervous System (CNS) Stimulant Drugs Companies Ranked by Revenue
3.3 Global Central Nervous System (CNS) Stimulant Drugs Revenue by Companies
3.4 Top 3 and Top 5 Central Nervous System (CNS) Stimulant Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Central Nervous System (CNS) Stimulant Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Central Nervous System (CNS) Stimulant Drugs Players in Global Market
3.6.1 List of Global Tier 1 Central Nervous System (CNS) Stimulant Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Central Nervous System (CNS) Stimulant Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Central Nervous System (CNS) Stimulant Drugs Market Size Markets, 2022 & 2030
4.1.2 Attention-deficit Hyperactivity Disorder
4.1.3 Narcolepsy
4.1.4 Others
4.2 By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue & Forecasts
4.2.1 By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2018-2023
4.2.2 By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2024-2030
4.2.3 By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Central Nervous System (CNS) Stimulant Drugs Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Research Institutes and Research Institutions
5.1.4 Clinic
5.1.5 Other
5.2 By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue & Forecasts
5.2.1 By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2018-2023
5.2.2 By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2024-2030
5.2.3 By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Central Nervous System (CNS) Stimulant Drugs Market Size, 2022 & 2030
6.2 By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue & Forecasts
6.2.1 By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2018-2023
6.2.2 By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2024-2030
6.2.3 By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Central Nervous System (CNS) Stimulant Drugs Revenue, 2018-2030
6.3.2 US Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.3.3 Canada Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.3.4 Mexico Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Central Nervous System (CNS) Stimulant Drugs Revenue, 2018-2030
6.4.2 Germany Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.4.3 France Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.4.4 U.K. Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.4.5 Italy Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.4.6 Russia Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.4.8 Benelux Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Central Nervous System (CNS) Stimulant Drugs Revenue, 2018-2030
6.5.2 China Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.5.3 Japan Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.5.4 South Korea Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.5.6 India Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Central Nervous System (CNS) Stimulant Drugs Revenue, 2018-2030
6.6.2 Brazil Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.6.3 Argentina Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue, 2018-2030
6.7.2 Turkey Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.7.3 Israel Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
6.7.5 UAE Central Nervous System (CNS) Stimulant Drugs Market Size, 2018-2030
7 Central Nervous System (CNS) Stimulant Drugs Companies Profiles
7.1 GlaxoSmithKline Plc
7.1.1 GlaxoSmithKline Plc Company Summary
7.1.2 GlaxoSmithKline Plc Business Overview
7.1.3 GlaxoSmithKline Plc Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.1.4 GlaxoSmithKline Plc Central Nervous System (CNS) Stimulant Drugs Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Plc Key News & Latest Developments
7.2 Johnson & Johnson Services Inc.
7.2.1 Johnson & Johnson Services Inc. Company Summary
7.2.2 Johnson & Johnson Services Inc. Business Overview
7.2.3 Johnson & Johnson Services Inc. Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.2.4 Johnson & Johnson Services Inc. Central Nervous System (CNS) Stimulant Drugs Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Services Inc. Key News & Latest Developments
7.3 Novartis AG
7.3.1 Novartis AG Company Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.3.4 Novartis AG Central Nervous System (CNS) Stimulant Drugs Revenue in Global Market (2018-2023)
7.3.5 Novartis AG Key News & Latest Developments
7.4 Pfizer Inc.
7.4.1 Pfizer Inc. Company Summary
7.4.2 Pfizer Inc. Business Overview
7.4.3 Pfizer Inc. Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.4.4 Pfizer Inc. Central Nervous System (CNS) Stimulant Drugs Revenue in Global Market (2018-2023)
7.4.5 Pfizer Inc. Key News & Latest Developments
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.5.3 Teva Pharmaceutical Industries Ltd. Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.5.4 Teva Pharmaceutical Industries Ltd. Central Nervous System (CNS) Stimulant Drugs Revenue in Global Market (2018-2023)
7.5.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Central Nervous System (CNS) Stimulant Drugs Market Opportunities & Trends in Global Market
Table 2. Central Nervous System (CNS) Stimulant Drugs Market Drivers in Global Market
Table 3. Central Nervous System (CNS) Stimulant Drugs Market Restraints in Global Market
Table 4. Key Players of Central Nervous System (CNS) Stimulant Drugs in Global Market
Table 5. Top Central Nervous System (CNS) Stimulant Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Central Nervous System (CNS) Stimulant Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Central Nervous System (CNS) Stimulant Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Central Nervous System (CNS) Stimulant Drugs Product Type
Table 9. List of Global Tier 1 Central Nervous System (CNS) Stimulant Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Central Nervous System (CNS) Stimulant Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Central Nervous System (CNS) Stimulant Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Central Nervous System (CNS) Stimulant Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Central Nervous System (CNS) Stimulant Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Central Nervous System (CNS) Stimulant Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2024-2030
Table 30. GlaxoSmithKline Plc Company Summary
Table 31. GlaxoSmithKline Plc Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 32. GlaxoSmithKline Plc Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. GlaxoSmithKline Plc Key News & Latest Developments
Table 34. Johnson & Johnson Services Inc. Company Summary
Table 35. Johnson & Johnson Services Inc. Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 36. Johnson & Johnson Services Inc. Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Services Inc. Key News & Latest Developments
Table 38. Novartis AG Company Summary
Table 39. Novartis AG Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 40. Novartis AG Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis AG Key News & Latest Developments
Table 42. Pfizer Inc. Company Summary
Table 43. Pfizer Inc. Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 44. Pfizer Inc. Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Inc. Key News & Latest Developments
Table 46. Teva Pharmaceutical Industries Ltd. Company Summary
Table 47. Teva Pharmaceutical Industries Ltd. Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 48. Teva Pharmaceutical Industries Ltd. Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
List of Figures
Figure 1. Central Nervous System (CNS) Stimulant Drugs Segment by Type in 2022
Figure 2. Central Nervous System (CNS) Stimulant Drugs Segment by Application in 2022
Figure 3. Global Central Nervous System (CNS) Stimulant Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Central Nervous System (CNS) Stimulant Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Central Nervous System (CNS) Stimulant Drugs Revenue in 2022
Figure 8. By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2018-2030
Figure 16. US Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2018-2030
Figure 28. China Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. GlaxoSmithKline Plc Central Nervous System (CNS) Stimulant Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Services Inc. Central Nervous System (CNS) Stimulant Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis AG Central Nervous System (CNS) Stimulant Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Inc. Central Nervous System (CNS) Stimulant Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Teva Pharmaceutical Industries Ltd. Central Nervous System (CNS) Stimulant Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
